Application Type
Patent
Application SubType
PCT National Phase
(10) Registration Number and Date
BNN20220022 16.11.2022
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
BN N/2022/0022 07.08.2020
(40) Publication Number and Date
BN N/2022/0022
A
16.11.2022
(86) PCT Filing Number and Date
(87) PCT Publication Number and Date
(85) National Entry Date
(30) Priority Details
JP 2019-148620
13.08.2019
(71/73) Applicant
(72) Inventor
(EN) Masahiro ITO : c/o Shinagawa Research and Development Center, SATO PHARMACEUTICAL CO., LTD., 8-5, Higashi-ohi 6-chome, Shinagawa-ku, Tokyo 140-0011 Japan
(EN) Kiyotaka MATSUI : c/o Shinagawa Research and Development Center, SATO PHARMACEUTICAL CO., LTD., 8-5, Higashi-ohi 6-chome, Shinagawa-ku, Tokyo 140-0011 Japan
(EN) Masami INUMA : c/o Shinagawa Research and Development Center, SATO PHARMACEUTICAL CO., LTD., 8-5, Higashi-ohi 6-chome, Shinagawa-ku, Tokyo 140-0011 Japan
(74) Representative Name
(EN) Drew & Napier LLC : c/o AIP Law, Unit 404A-410A, 4th Floor, Wisma Jaya, Jalan Pemancha, Bandar Seri Begawan BS8811, Brunei Darussalam
(54) Title
(EN) PHARMACEUTICAL COMPOSITION CONTAINING ANTIFUNGAL AGENT AS ACTIVE INGREDIENT
(57) Abstract
(EN)
The present invention provides a technique that allows a pharmaceutical composition, preferably for external use, containing luliconazole or the like to contain luliconazole or the like at a high concentration, and suppresses the precipitation thereof over time. The present invention uses a polyethylene glycol having an average molecular weight of 380 to 420 represented by a formula HOCH2(CH2OCH2),CH2OH (where n is an integer), ethanol, benzyl alcohol, lactic acid, propylene carbonate, and acetone in combination with the luliconazole or the like.
(58) Citations